Back

Role of NT-proBNP evaluations in risk stratification of patients with heart failure within one year follow-up

22 May 2016 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Biomarkers Prognosis (using biomarkers) HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Federico Angelo Immordino

University Hospital Paolo Giaccone, Palermo (Italy)

26 More presentations in this session

Presentation thumbnail
Doctor T. Mueller (Voecklabruck, AT)
Abstract
Presentation thumbnail
Doctor D. Vranes (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Doctor J. Zhang (Chelmsford, GB)
Abstract Slides
Presentation thumbnail
Professor S. Apostolovic (Nis, RS)
Abstract
Presentation thumbnail
Professor A. Jabor (Prague, CZ)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Biomarkers

The Event

Event poster

HEART FAILURE 2016

22 May 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Serum NT-proBNP as a short-term predictor for patients with stable heart failure
21 May 2023
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025
thumbnail
Congress Presentation
Approaches to developing a standardized screening and intervention strategy in patients with coronary artery disease and type 2 diabetes mellitus at risk of heart failure
18 May 2025
thumbnail
Congress Presentation
NT-proBNP as a prognostic biomarker in acute de novo heart failure: insights from the COMFE registry
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources